Human Bioequivalence Test of Liraglutide Injection
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the bioequivalence of The liraglutide injection produced by Chia Tai Tianqing
Pharmaceutical Group Co., Ltd. and Victoza® produced by Novo Nordisk (China) Pharmaceutical
Co., Ltd for single dose in healthy subjects,so as to provide reference for clinical
evaluation and clinical medication;To observe the safety of the test preparation liraglutide
injection and the reference preparation Victoza ® in healthy subjects.